Viewing Study NCT01222767


Ignite Creation Date: 2025-12-25 @ 12:34 AM
Ignite Modification Date: 2025-12-25 @ 10:43 PM
Study NCT ID: NCT01222767
Status: COMPLETED
Last Update Posted: 2021-10-29
First Post: 2010-10-08
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Study of Zalypsis® (PM00104) in Patients With Unresectable Locally Advanced and/or Metastatic Ewing Family of Tumors (EFT) Progressing After at Least One Prior Line of Chemotherapy
Sponsor: PharmaMar
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2010-12
Start Date Type: None
Primary Completion Date: 2012-04
Primary Completion Date Type: ACTUAL
Completion Date: 2012-04
Completion Date Type: ACTUAL
First Submit Date: 2010-10-08
First Submit QC Date: None
Study First Post Date: 2010-10-18
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2021-07-13
Results First Submit QC Date: None
Results First Post Date: 2021-10-29
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2021-09-30
Last Update Post Date: 2021-10-29
Last Update Post Date Type: ACTUAL